Global X - S&P Biotech ETF
ETFYour view on CURE.AX
Global X - S&P Biotech ETF
ETFGlobal XSentiment
AUM (AUD)
$48.74M
Expense Ratio
0.45%
Holdings
0
Sentiment
Overview for Global X - S&P Biotech ETF
- Fund Type
- ETF
- Fund Issuer
- Global X
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- November 8, 2018
- Domicile
- AU
- Fund Type
- ETF
- Fund Issuer
- Global X
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- November 8, 2018
- Domicile
- AU
- Fund Type
- ETF
- Fund Issuer
- Global X
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- November 8, 2018
- Domicile
- AU
About this fund
The Global X S&P Biotech ETF, identified by its ticker CURE, endeavors to replicate the overall financial performance, encompassing both capital gains and dividends, of the S&P Biotechnology Select Industry Index, before any management fees and operational costs are deducted.
CURE.AX Stock Price
Key Facts
EquityExpense Ratio
0.45%
AUM
$48.74M
Fund Details
Expense Ratio
0.45%
Assets Under Management
$48.74M
NAV
$75.68 AUD
Average Volume
2.1K
Inception Date
November 8, 2018
Asset Class
Equity
Fund Issuer
Global X
Domicile
AU
ISIN
AU0000028110
NAV Currency
AUD
Expense Ratio
0.45%
Assets Under Management
$48.74M
NAV
$75.68 AUD
Average Volume
2.1K
Inception Date
November 8, 2018
Asset Class
Equity
Fund Issuer
Global X
Domicile
AU
ISIN
AU0000028110
NAV Currency
AUD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.